Clarivate Plc is a provider of intelligence, workflow, and tech-enabled services supporting the innovation lifecycle across academia, government, intellectual property, and life sciences. The company operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. In Academia & Government, it offers research discovery, content solutions, and library software, serving academic institutions, libraries, and government bodies. The Intellectual Property segment provides patent and trademark data, management software, and maintenance services to corporations and law firms. The Life Sciences & Healthcare segment delivers intelligence platforms for pharmaceutical, biotechnology, and medical device companies to support research, development, commercialization, and supply chain management. Clarivate serves customers worldwide, including academic institutions, research organizations, corporations, law firms, and government entities. The company was incorporated in 2019 and became a public company in May 2019. It divested its ScholarOne and Valipat businesses in 2024.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Information Technology Services Homepage clarivate.com
Sector Technology IR page ir.clarivate.com
Tags
research intelligence, library software, patent management, trademark services, life sciences data, academic publishing, ai research assistants, scientific databases, ip analytics, pharmaceutical intelligence, Web of Science, ProQuest, Ex Libris, Innovative, Alma, Vega, Polaris, Derwent World Patent Index, Darts-ip, CompuMark, IPOne, Clarivate Academic AI, Web of Science Research Intelligence, Derwent Patent Intelligence
Press page clarivate.com/news

Metrics

Valuation  
Market cap $ 1.069B
Market cap (USD) $ 1.069B
P/E -5.57
PEG —
P/BV 0.24
P/S 0.47
P/OCF 1.91
P/FCF 3.32
Dividend yield —
Turnover / mcap —
Returns  
ROE -4.0%
ROI -2.2%
ROIC 0.58%
Profit margin -8.2%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 91.3%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 72
Quality score 11.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Revenue 2.455B 2.557B 2.629B 2.66B 1.877B 1.254B 974.345M 968.468M
Net profit -201.1M -636.7M -911.2M -3.96B -270.448M -106.31M -210.977M -242.162M
Free cash flow 365.3M 357.5M 501.7M 306.4M 205.224M 155.787M — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Share price 3.34 5.08 9.26 8.34 23.52 29.71 16.8 —
Price performance 12m -0.34 -0.45 0.11 -0.65 -0.21 0.77 — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 362M 318M 331M 334M 751M 906M 872M 908M 798M 822M
↳ YoY growth -12.1% +4.2% +0.8% +125.1% +20.6% -3.8% +4.2% -12.1% +2.9%
↳ 5y CAGR +20.2% +22.4% +22.3% +19.0% +1.8%
Borrowings, current (USD) — — 60.3M 9M 28.6M 30.6M 1M 1.2M 1.3M 102M
Borrowings, non-current (USD) — — 1.93B 1.63B 3.46B 5.46B 5.01B 4.72B 4.52B 4.32B
Lease liabilities (USD) — — 0.00 86.3M 140M 157M 130M 118M 103M 84.4M
Cash and deposits (USD) 77.1M 53.2M 25.6M 76.1M 258M 431M 349M 371M 295M 329M
Intangible assets (USD) — — 1.96B 1.83B 7.37B 10.4B 9.44B 9.01B 8.44B 8.01B
Right-of-use assets (USD) — — 0.00 85.4M 132M 86M 58.9M 55.2M 53.6M 46.6M
Net debt (borrowings + leases - cash) (USD) — — 1.96B 1.65B 3.37B 5.21B 4.79B 4.47B 4.33B 4.18B
Cash flow detail
Operating cash flow (USD) — 6.67M -26.1M 118M 264M 324M 509M 744M 647M 629M
Purchases of property, plant and equipment (USD) — — -45.4M -69.8M -108M -119M -203M -243M -289M -263M
Purchases of intangible assets (USD) — — 0.00 -2.63M -5.98M 0.00 — — — —
Change in receivables (cash effect) (USD) — 43.1M -50.9M -593,000 16.2M -64.1M -28.3M -25.5M 92.6M -5M
Change in payables (cash effect) (USD) — -39.7M -18.1M -13.8M -2.85M 31.2M -24M 41.2M -15M 22.8M
Dividends paid (cash effect) (USD) — — — — 0.00 -18.9M -75.4M -75.5M -37.7M 0.00
Interest paid (cash effect) (USD) — -115M -122M -101M -97.5M -182M -252M -274M -265M -256M
Income taxes paid (cash effect) (USD) — -14.7M -13.2M -29.2M -27.6M -33.9M -63.7M -42.9M -52.9M -42.1M
Share-based compensation (USD) — 17.7M 13.7M 51.4M 35.4M 33.3M 93.9M 109M 59.9M 63.1M
Operating cash flow before change in receivables (USD) — -36.4M 24.8M 118M 247M 388M 538M 770M 554M 634M
Free cash flow (OCF - PPE - intangibles) (USD) — — -71.5M 45.1M 150M 205M 306M 502M 358M 365M
Income detail
Total comprehensive income (USD) — -246M -251M -221M 402M -436M -4.95B -741M -668M -128M
Comprehensive income to owners (USD) — -246M -251M -221M 402M -436M -4.95B -741M -668M -128M
Provision for credit losses (USD) — 6.51M 6.51M 1.33M 3.33M 5.99M — — — —
Credit cost ratio (credit losses / average receivables) (%) — 1.9% 2.0% 0.4% 0.6% 0.7% — — — —
Reported Mar 2, 2020 Mar 2, 2020 Feb 26, 2021 Feb 26, 2021 Mar 1, 2023 Mar 10, 2022 Mar 1, 2023 Feb 27, 2024 Feb 19, 2025 Feb 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

LONDON, November 12, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offers (collectively, the "Offers") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), to purchase the outstanding 3.875% Senior Secured Notes due 2028 (the "2028 Notes") for aggregate principal amount of up to $400,000,000 (the “2028 Notes Series Cap”) and the outstanding 4.875% Senior Notes due 2029 (the "2029 Notes" and, together with the 2028 Notes, the “Notes” and, each, a “Series of Notes”) for aggregate principal amount of up to $100,000,000 (the “2029 Notes Series Cap” and, together with the 2028 Notes Series Cap, each, a “Series Cap”), in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 4, 2026 (the "Offer to Purchase") and any related documents (collectively with the Offer to Purchase, the "Tender Offer Documents").

LONDON, November 10, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield with respect to the 2028 Notes and the 2028 Notes Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offers (collectively, the "Offers") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 4, 2026 (the "Offer to Purchase").

LONDON, November 4, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), has commenced cash tender offers (collectively, the "Offers") to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 4, 2026 (the "Offer to Purchase").

The Company is offering to purchase in the Offers its 3.875% Senior Secured Notes due 2028 (the “2028 Notes”) and its 4.875% Senior Notes due 2029 (the “2029 Notes” and, together with the 2028 Notes, the “Notes” and, each, a “Series of Notes”) for the applicable consideration described below, subject to a $500,000,000 cap on the aggregate principal amount of Notes purchased in the Offers (the "Tender Cap"), proration and the terms and conditions, including, among others, a $400,000,000 cap on the aggregate principal amount of the 2028 Notes to be purchased and a $100,000,000 cap on the aggregate principal amount of the 2029 Notes to be purchased pursuant to the Offers (each, a “Series Cap”) set forth i

Prompts

Clarivate Plc (ticker CLVT), listed in United States.

Company History

Date Change Detail
Mar 9, 2020 Renamed CLARIVATE ANALYTICS PLC → CLARIVATE PLC

ETFs Holding Clarivate Plc

ETF Weight in ETF Shares Market value As of
BSVO 0.23% 2,472,823 $ 5.42M Nov 18, 2026
CDX short -0.23% -256,195.8857 $ -561.069K Nov 17, 2026
AVUV 0.12% 16,416,854 $ 37.595M Nov 16, 2026
DFSV 0.06% 7,399,132 $ 17.018M Nov 12, 2026
AVSC 0.05% 707,063 $ 1.619M Nov 16, 2026
DFAT 0.02% 2,597,089 $ 5.973M Nov 12, 2026
DXUV 0.00% 26,428 $ 60.784K Nov 12, 2026
MSLC 0.00% 5,888 $ 12.07K Aug 31, 2026
DCOR 0.00% 28,800 $ 66.24K Nov 12, 2026
DFAS 0.00% 14,347 $ 32.998K Nov 12, 2026
EBI 0.00% 60 $ 123.00 Aug 31, 2026
AVUS 0.00% 112,722 $ 258.133K Nov 16, 2026
AVSU 0.00% 3,778 $ 8,651.62 Nov 16, 2026
AVMV 0.00% 40 $ 91.60 Nov 16, 2026